Tue.Dec 03, 2024

article thumbnail

The Sweet Superfood Every Woman Over 40 Needs

Alison Bladh

The Sweet Superfood: Health Benefits of Dates for Women Over 40 Dates, often called "nature's candy," have been enjoyed for centuries as a delicious and nutrient-packed fruit. For women over 40, dates are an excellent way to boost energy, support digestive health, and promote overall well-being. Packed with essential vitamins, minerals, and fibre, they’re a simple addition to your diet that can make a big impact on your health.

Diet 59
article thumbnail

Clinical Characteristics and Management of Late-Onset Vitiligo

Dermatology Times

LOV has unique clinical traits, epidemiology, and treatment responses compared to early-onset vitiligo, underscoring the need for a tailored management approach.

Clinic 63
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2024 US Holiday Online Beauty Sales Are Up More than 8% So Far: Adobe Analytics

Beauty Launchpad

Per Adobe Analytics, "57% of online sales came through a mobile device on Cyber Monday," a gain of 13.3%, year-over-year.

Sales 52
article thumbnail

Johnson & Johnson Seeks U.S. FDA Approval for Guselkumab (Tremfya) in Pediatric PsO and jPsA

The Dermatology Digest

Johnson & Johnson submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval of guselkumab (Tremfya) for the treatment of children 6 and older with moderate-to-severe plaque psoriasis (PsO) and children 5 and up with active juvenile psoriatic arthritis (jPsA). Guselkumab is the first approved monoclonal antibody that selectively binds to the p19 subunit of interleukin (IL)-23 and inhibits its interaction with the IL-23 re

Safety 41
article thumbnail

The Shifting Aging Mentality

Skin Inc

When did we begin to fear aging? Journey with us, as we explore beauty's obsession with beating father time and explore how this conversation is starting to change.

article thumbnail

Psychosocial Burden and Quality of Life of Patients with Atopic Dermatitis

Dermatology Times

Panelists discuss how atopic dermatitis significantly impacts patients' mental health, social relationships, and daily activities, creating substantial psychosocial burdens that can lead to anxiety, depression, and reduced quality of life.

More Trending

article thumbnail

Balancing Patient Needs and Telemedicine Considerations

Dermatology Times

Panelists discuss how health care providers must balance the convenience and accessibility of telemedicine with individual patient needs and clinical considerations when delivering dermatological care.

Clinic 36
article thumbnail

Delgocitinib Reduces Inflammation and Restores Skin Barrier in CHE as a Topical Pan-JAK Inhibitor

Dermatology Times

Treatment with delgocitinib led to a significant decrease in the expression of inflammatory markers that were elevated in severe cases compared with mild cases at baseline.

article thumbnail

The Effect of Atopic Dermatitis Across Patient Populations

Dermatology Times

Panelists discuss how atopic dermatitis impacts different demographic groups through variations in disease presentation, treatment access, and quality of life outcomes.

article thumbnail

Apogee Announces Clinical Trial Advancements in APG777 for AD Treatment

Dermatology Times

Promising new data was released along with a timeline of upcoming studies evaluating potential combination therapies for atopic dermatitis.

Clinic 36
article thumbnail

Reviewing Key Clinician Insights and Innovations in Vitiligo Care This Year

Dermatology Times

Explore key insights and innovations in vitiligo from 2024, from treatment advances to patient-focused strategies.

article thumbnail

Regenerative Medicine Proves to Be Effective for Vitiligo Treatment

Dermatology Times

Regenerative methods such as cell therapy and platelet-rich plasma showed promising results in patient repigmentation.